Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis

Journal of Clinical Oncology

Volumn 14, Issue 7, 1996, Pages 2091-2097

  Mellado, B ^a   Colomer, D ^a   Castel, T ^a   Munoz M ^a   Carballo, E ^a   Galan M ^a   Mascaro J M ^a   Vives Corrons, J L ^a   Grau, J J ^a   Estape J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 8944230185     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.7.2091     Document Type: Article

References (35)

1. Koh HK: Cutaneous melanoma. N Engl J Med 325:171-181, 1991
2. Goldstein AM, Tucker M: Etiology, epidemiology, risk factors and public health issues of melanoma. Curr Opin Oncol 5:358-363, 1993
3. Steffens TA, Livingston PO: The status of adjuvant therapy of melanoma. Surg Oncol Clin North Am 1:307-333, 1992
4. Barth A, Morton DL: The role of adjuvant therapy in melanoma management. Cancer 75:726-734, 1995
5. Livingston PO, Wong GYC, Adluri S, et al: Improved survival in stage III melanoma patients with GM2 antibodies. A randomized trial of adjuvant vaccination with GM2 ganglioside. J Clin Oncol 12:1036-1044, 1994
6. Brugger W, Bross KJ, Glatt M, et al: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636-649, 1994
7. Rill DR, Santana VM, Roberts WM, et al: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380-383, 1994
8. Saiki RK, Gelfand D, Stoffel S, et al: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 230:1350-1354, 1985
9. Smith B, Selby P, Southgate J, et al: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338:1227-1229, 1991
10. Hoon DSB, Wang Y, Dale PS, et al: Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13:2109-2116, 1995
11. l1. Brossart P, Shmier JW, Krüger S, et al: A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 55:4065-4068, 1995
12. Naito H, Kuzumaki N, Uchino J-I, et al: Detection of tyrosine hydroxilase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 27:762-765, 1991
13. Mattano LA, Moss TJ, Emerson SG: Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52:4701-4705, 1992
14. Datta IH, Adams PT, Drobyski WR, et al: Sensitive detection of occult breast cancer by the reverse- transcriptase polymerase chain reaction. J Clin Oncol 12:475-482, 1994
15. Moreno JG, Croce Carlo M, Fischer R, et al: Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52:6110-6112, 1992
16. Seiden MV, Kantoff PW, Krithivas K, et al: Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 12:2634-2639, 1994
17. Komeda T, Fukuda Y, Sando T, et al: Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 75:2214-2219, 1995
18. Matsumura M, Niwa Y, Kato N, et al: Detection of alphaprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: A possible predictor of metastatic hepatocellular carcinoma. Hepatology 20:1418-1425, 1995
19. Hillaire S, Barbu V, Boucher E, et al: Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenteroloy 106:239-242, 1994
20. Gerhard M, Juhl M, Kalthoff H, et al: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 12:725-729, 1994
21. Boyum A: Separation of leukocytes from blood and bone marrow. Scand Clin Invest 21:51-55, 1968
22. Chomczynski P, Sacchi N: Single-step method for RNA isolation by acid guanidinium thyocianate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
23. Cox DR: Partial likelihood. Biometrika 62:457-481, 1975
24. Delage R, Soiffer RJ, Dear K, et al: Clinical significance of BCR-ABL gene rearrangement detected by polymerase chain reaction after allogenic bone marrow transplantation in chronic myelogenous leukemia. Blood 78:2759-2767, 1991
25. Biondi A, Yokota S, Hansen-Hagge TE, et al: Minimal residual disease in childhood acute lymphoblastic leukemia: Analysis of patients in continuos complete remission or with consecutive relapse. Leukemia 6:282-288, 1992
26. Ito Y, Wasserman R, Galili N, et al: Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia. J Clin Oncol 11:546-553, 1993
27. Price CGA, Meerabux J, Murtag S, et al: The significance of circulating cells carrying t(14;18) in long-term remission from follicular lymphoma. J Clin Oncol 9:1527-1532, 1991
28. Hardinghamje JE, Kotase CD, Sage RE, et al: Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol 13:1073-1079, 1995
29. Berinstein NL, Reis MD, Ngan B, et al: Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced follicular lymphoma. J Clin Oncol 11:1344-1352, 1993
30. Negrin RJ, Pesando J: Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations. J Clin Oncol 12:1021-1027, 1994
31. Kaplan JC, Kann A, Chelly J: Illegitimate transcription: Its use in the study of inherited diseases. Human Mutat 1:357-360, 1992
32. Sarkar G, Sommer JS: Access to a messenger RNA sequence or its protein product is no limited by tissue of species specificity. Science 244:331-334, 1989
33. Koop S, MacDonald IC, Schmidt EE, et al: Fate of melanoma cells entering the microcirculation: Over 80% survive and extravasate. Cancer Res 55:2520-2523, 1995
34. Clark WH: Tumor progression and the nature of cancer. Br J Cancer 64:631-644, 1991
35. Liotta LA, Kleinerman J, Saideg GM: Quantitative relationship of intravascular tumor cells, tumor vessels and pulmonary metastasis following tumor implantation. Cancer Res 34:997-1003, 1974